Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIMESKIN 2 long-term dimethyl fumarate study in chronic plaque psoriasis
2017-003818-11Phase 3Completed
- Sponsor
- Almirall
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dimethyl fumarate in psoriasis, sponsored by Almirall. Primary endpoint: PASI 75 response at 1 year. Started Jun 2020; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2017-003818-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003818-11.